The Price Family Center for Comprehensive Chest Care offers a complete continuum of care for the full spectrum of lung diseases and disorders, from the most manageable to the most complex — including lung cancer, chronic obstructive pulmonary disease (COPD), and interstitial lung disease.
The Price Family Center includes the following Programs and Centers:
- Center for Acute Respiratory Failure/Medical ECMO Program
- Center for Hyperhidrosis
- Center for Lung Disease and Transplantation
- Esophageal Disorders Program
- High-Risk Lung Assessment Program
- Interventional Bronchoscopy and Endobronchial Therapy Program
- Women’s Lung and Health Center
Center for Acute Respiratory Failure/Medical ECMO Program treats adult patients who rapidly develop respiratory failure—typically from acute respiratory distress syndrome, pneumonia, trauma, pulmonary embolism, or flare-ups of chronic lung diseases such as asthma, emphysema, or cystic fibrosis—who require advanced therapeutic interventions. The most advanced of these interventions is Extracorporeal Membrane Oxygenation (ECMO).
The Center for Hyperhidrosis at NewYork-Presbyterian/Columbia University Medical Center (NYP/Columbia) has been a leader in the diagnosis and treatment of hyperhidrosis (excessive sweating) in the New York Metropolitan area for many years. The center offers a team approach to hyperhidrosis treatment, offering both medical and minimally invasive surgical therapies, including endoscopic thoracic sympathectomy (ETS).
The NewYork-Presbyterian Center for Lung Disease and Transplantation at Columbia University Medical Center is a leading center in the field of lung transplantation and has received Medicare approval as a center of excellence in lung transplantation. Lung transplant may be indicated for patients with conditions including cystic fibrosis, emphysema and interstitial lung disease. Our faculty includes thoracic surgeons and pulmonologists solely dedicated to the care of patients undergoing lung transplantation. Our outcomes are a testament to our expertise; one-year survival following lung transplant is 92%, far superior to the results of many highly regarded transplant programs in the country.
Gastrointestinal specialists at NYP/Columbia's Esophageal Disorders Program offer the latest advances in the management of gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal cancer, swallowing disorders, achalasia, and hiatal hernias. These conditions are the focus of key prevention, diagnostic, and treatment programs.
The High-Risk Lung Assessment Program provides assessment, follow-up care, and ongoing testing when necessary, for those who have been found to have respiratory symptoms such as a chronic cough or an abnormality on an imaging study, as well as for those at risk for pulmonary disease due to family history, smoking, or environmental exposures. The program draws upon resources at NewYork-Presbyterian/Columbia University Medical Center to help patients mitigate risk factors, as well as to facilitate rapid referral to additional experts as needed, including the lung cancer team, the interstitial lung disease program, and the lung failure and transplant team.
Interventional Bronchoscopy and Endobronchial Therapy Program was jointly founded by the departments of medicine and surgery at NewYork-Presbyterian/Columbia University Medical Center for the treatment of patients with endobronchial tumors or tracheobronchial obstructions. The program draws upon the resources of NYP/Columbia, offering a full range of diagnostic and therapeutic options for patients with benign or malignant airway pathology.